2017-2018 Drug Updates in Hematologic Malignancies
Presented by Rebecca J. Nelson, PharmD, BCOP
Moffitt Cancer Center and Research Institute, Tampa, Florida
Presenter’s disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2019;10(3):225–229 |
© 2019 Harborside™
Presented by Rebecca J. Nelson, PharmD, BCOP, Dr. Nelson discussed the pharmacology and indications of medications approved from 2017 to 2018 for the management of patients with hematologic malignancies.
For access to the full length article, please sign in